{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:31:49Z","timestamp":1792801909199,"version":"4.5.0"},"reference-count":47,"publisher":"American Society of Hematology","issue":"15","license":[{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,13]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Among the most common genetic alterations in myelodysplastic syndromes (MDS) are mutations in the spliceosome gene SF3B1. Such mutations induce specific RNA missplicing events, directly promote ring sideroblast (RS) formation, and generally associate with a more favorable prognosis. However, not all SF3B1 mutations are the same, and little is known about how distinct hotspots influence disease. Here, we report that the E592K variant of SF3B1 associates with high-risk disease features in MDS, including a lack of RS, increased myeloblasts, a distinct comutation pattern, and a lack of favorable survival seen with other SF3B1 mutations. Moreover, compared with other hot spot SF3B1 mutations, E592K induces a unique RNA missplicing pattern, retains an interaction with the splicing factor SUGP1, and preserves normal RNA splicing of the sideroblastic anemia genes TMEM14C and ABCB7. These data have implications for our understanding of the functional diversity of spliceosome mutations, as well as the pathobiology, classification, prognosis, and management of SF3B1-mutant MDS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023011260","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T14:55:52Z","timestamp":1715957752000},"page":"3961-3971","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":11,"title":["The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts"],"prefix":"10.1182","volume":"8","author":[{"given":"In Young","family":"Choi","sequence":"first","affiliation":[{"name":"1The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Ling","sequence":"additional","affiliation":[{"name":"2Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"3Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"4Kavli Neuroscience Discovery Institute, Johns Hopkins University, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[{"name":"5Department of Biological Sciences, Columbia University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Helmenstine","sequence":"additional","affiliation":[{"name":"1The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5083-9838","authenticated-orcid":false,"given":"Wencke","family":"Walter","sequence":"additional","affiliation":[{"name":"6Munich Leukemia Laboratory, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8823-9507","authenticated-orcid":false,"given":"Panagiotis","family":"Tsakiroglou","sequence":"additional","affiliation":[{"name":"1The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0946-8913","authenticated-orcid":false,"given":"Riley E.","family":"Bergman","sequence":"additional","affiliation":[{"name":"7Division of Hematology, Oncology, Department of Medicine, Vanderbilt University Medical Center and The Vanderbilt-Ingram Cancer Center, Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8546-3893","authenticated-orcid":false,"given":"C\u00e9line","family":"Philippe","sequence":"additional","affiliation":[{"name":"8Barts Cancer Institute, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Manley","sequence":"additional","affiliation":[{"name":"5Department of Biological Sciences, Columbia University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7671-7364","authenticated-orcid":false,"given":"Kevin","family":"Rouault-Pierre","sequence":"additional","affiliation":[{"name":"8Barts Cancer Institute, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[{"name":"9State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China"},{"name":"10MDS and MPN Centre, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Wiseman","sequence":"additional","affiliation":[{"name":"11Epigenetics of Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom"},{"name":"12Department of Haematology, The Christie NHS Foundation Trust, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Batta","sequence":"additional","affiliation":[{"name":"11Epigenetics of Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom"},{"name":"12Department of Haematology, The Christie NHS Foundation Trust, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Ouseph","sequence":"additional","affiliation":[{"name":"13Division of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2057-7187","authenticated-orcid":false,"given":"Elsa","family":"Bernard","sequence":"additional","affiliation":[{"name":"14Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"15Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Dubner","sequence":"additional","affiliation":[{"name":"1The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[{"name":"16Department of Hematology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Haferlach","sequence":"additional","affiliation":[{"name":"6Munich Leukemia Laboratory, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Koget","sequence":"additional","affiliation":[{"name":"17Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Fazal","sequence":"additional","affiliation":[{"name":"17Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6854-773X","authenticated-orcid":false,"given":"Tania","family":"Jain","sequence":"additional","affiliation":[{"name":"1The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9541-2192","authenticated-orcid":false,"given":"Christopher D.","family":"Gocke","sequence":"additional","affiliation":[{"name":"1The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD"},{"name":"2Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E.","family":"DeZern","sequence":"additional","affiliation":[{"name":"1The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1314-0534","authenticated-orcid":false,"given":"William Brian","family":"Dalton","sequence":"additional","affiliation":[{"name":"1The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,7,26]]},"reference":[{"issue":"2","key":"2024081315054480300_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/leu.2013.336","article-title":"Landscape of genetic lesions in 944 patients with myelodysplastic syndromes","volume":"28","author":"Haferlach","year":"2014","journal-title":"Leukemia"},{"issue":"5","key":"2024081315054480300_bib2","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.celrep.2015.09.053","article-title":"Cancer-associated SF3B1 hotspot mutations induce cryptic 3\u2032 splice site selection through use of a different branch point","volume":"13","author":"Darman","year":"2015","journal-title":"Cell Rep"},{"issue":"500","key":"2024081315054480300_bib3","doi-asserted-by":"crossref","first-page":"eaav5467","DOI":"10.1126\/scitranslmed.aav5467","article-title":"A\u00a0variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome","volume":"11","author":"Bondu","year":"2019","journal-title":"Sci Transl Med"},{"issue":"685","key":"2024081315054480300_bib4","doi-asserted-by":"crossref","first-page":"eabn5135","DOI":"10.1126\/scitranslmed.abn5135","article-title":"Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1-mutated myelodysplasia","volume":"15","author":"Mian","year":"2023","journal-title":"Sci Transl Med"},{"issue":"13","key":"2024081315054480300_bib5","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood.2021012652","article-title":"Coordinated mis-splicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome","volume":"139","author":"Clough","year":"2022","journal-title":"Blood"},{"issue":"2","key":"2024081315054480300_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccell.2018.07.003","article-title":"Synthetic lethal and convergent biological effects of cancer-associated spliceosomal gene mutations","volume":"34","author":"Lee","year":"2018","journal-title":"Cancer Cell"},{"key":"2024081315054480300_bib7","doi-asserted-by":"crossref","first-page":"e78136","DOI":"10.7554\/eLife.78136","article-title":"Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations","volume":"11","author":"Choudhary","year":"2022","journal-title":"Elife"},{"issue":"8","key":"2024081315054480300_bib8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1182\/blood.2021015325","article-title":"Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia","volume":"140","author":"Tanaka","year":"2022","journal-title":"Blood"},{"issue":"24","key":"2024081315054480300_bib9","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1182\/blood-2011-09-377275","article-title":"Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic\/myeloproliferative neoplasms","volume":"118","author":"Malcovati","year":"2011","journal-title":"Blood"},{"issue":"7","key":"2024081315054480300_bib10","first-page":"EVIDoa2200008","article-title":"Molecular International Prognostic Scoring System for Myelodysplastic Syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"Nejm \u00c9vid"},{"issue":"11","key":"2024081315054480300_bib11","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1200\/JCO.20.01659","article-title":"Classification and personalized prognostic assessment on the basis of clinical and genomic features in myelodysplastic Syndromes","volume":"39","author":"Bersanelli","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"33","key":"2024081315054480300_bib12","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.20.02810","article-title":"Personalized prediction model to risk stratify patients with myelodysplastic syndromes","volume":"39","author":"Nazha","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"2024081315054480300_bib13","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1182\/bloodadvances.2019001127","article-title":"The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing","volume":"4","author":"Dalton","year":"2020","journal-title":"Blood Adv"},{"issue":"8","key":"2024081315054480300_bib14","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","article-title":"AACR Project GENIE: powering precision medicine through an international consortium","volume":"7","author":"Andr\u00e9","year":"2017","journal-title":"Cancer Discov"},{"issue":"7601","key":"2024081315054480300_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nature17664","article-title":"Efficient introduction of specific homozygous and heterozygous mutations using CRISPR\/Cas9","volume":"533","author":"Paquet","year":"2016","journal-title":"Nature"},{"issue":"11","key":"2024081315054480300_bib16","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1172\/JCI125022","article-title":"Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation","volume":"129","author":"Dalton","year":"2019","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"2024081315054480300_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"1","key":"2024081315054480300_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41467-019-14020-5","article-title":"ASCOT identifies key regulators of neuronal subtype-specific splicing","volume":"11","author":"Ling","year":"2020","journal-title":"Nat Commun"},{"issue":"7","key":"2024081315054480300_bib19","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"issue":"1","key":"2024081315054480300_bib20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.molcel.2019.07.017","article-title":"Disease-causing mutations in SF3B1 alter splicing by disrupting interaction with SUGP1","volume":"76","author":"Zhang","year":"2019","journal-title":"Mol Cell"},{"issue":"1","key":"2024081315054480300_bib21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.celrep.2018.01.088","article-title":"Somatic mutational landscape of splicing factor genes and their functional consequences across 33 cancer types","volume":"23","author":"Seiler","year":"2018","journal-title":"Cell Rep"},{"key":"2024081315054480300_bib22","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.csbj.2021.02.012","article-title":"Functional and conformational impact of cancer-associated SF3B1 mutations depends on the position and the charge of amino acid substitution","volume":"19","author":"Canbezdi","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"issue":"13","key":"2024081315054480300_bib23","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1182\/blood.2020006868","article-title":"Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms","volume":"136","author":"Taylor","year":"2020","journal-title":"Blood"},{"key":"2024081315054480300_bib24","doi-asserted-by":"crossref","first-page":"gkw1349","DOI":"10.1093\/nar\/gkw1349","article-title":"SF3b1 mutations associated with myelodysplastic syndromes alter the fidelity of branchsite selection in yeast","volume":"45","author":"Carrocci","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"15","key":"2024081315054480300_bib25","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","article-title":"Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts","volume":"365","author":"Papaemmanuil","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"2024081315054480300_bib26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.molcel.2016.08.036","article-title":"Molecular architecture of SF3b and structural consequences of its cancer-related mutations","volume":"64","author":"Cretu","year":"2016","journal-title":"Mol Cell"},{"issue":"4","key":"2024081315054480300_bib27","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/s41375-020-1002-y","article-title":"Complex landscape of alternative splicing in myeloid neoplasms","volume":"35","author":"Hershberger","year":"2021","journal-title":"Leukemia"},{"issue":"4","key":"2024081315054480300_bib28","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/bjh.13610","article-title":"Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts","volume":"171","author":"Conte","year":"2015","journal-title":"Br J Haematol"},{"issue":"11","key":"2024081315054480300_bib29","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: integrating morphological, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"7","key":"2024081315054480300_bib30","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"2","key":"2024081315054480300_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood.2020004850","article-title":"SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS","volume":"136","author":"Malcovati","year":"2020","journal-title":"Blood"},{"issue":"7","key":"2024081315054480300_bib32","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/s41587-022-01224-2","article-title":"Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells","volume":"40","author":"North","year":"2022","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2024081315054480300_bib33","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1038\/s41467-022-33523-2","article-title":"Cell-specific regulation of gene expression using splicing-dependent frameshifting","volume":"13","author":"Ling","year":"2022","journal-title":"Nat Commun"},{"issue":"7778","key":"2024081315054480300_bib34","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41586-019-1646-9","article-title":"Spliceosomal disruption of the non-canonical BAF complex in cancer","volume":"574","author":"Inoue","year":"2019","journal-title":"Nature"},{"issue":"6","key":"2024081315054480300_bib35","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/nm.4097","article-title":"Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins","volume":"22","author":"Lee","year":"2016","journal-title":"Nat Med"},{"issue":"7367","key":"2024081315054480300_bib36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"},{"issue":"3","key":"2024081315054480300_bib37","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.molcel.2017.12.029","article-title":"The augmented R-loop is a unifying mechanism for myelodysplastic syndromes induced by high-risk splicing factor mutations","volume":"69","author":"Chen","year":"2018","journal-title":"Mol Cell"},{"issue":"12","key":"2024081315054480300_bib38","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1182\/blood-2018-04-843771","article-title":"Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes\/pathways and clinical associations","volume":"132","author":"Pellagatti","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2024081315054480300_bib39","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1038\/s41467-018-06063-x","article-title":"Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia","volume":"9","author":"Shiozawa","year":"2018","journal-title":"Nat Commun"},{"issue":"5","key":"2024081315054480300_bib40","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ccell.2015.04.006","article-title":"SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition","volume":"27","author":"Kim","year":"2015","journal-title":"Cancer Cell"},{"issue":"13","key":"2024081315054480300_bib41","first-page":"1032","article-title":"Rare and private spliceosomal gene mutations drive partial, complete, and dual phenocopies of hotspot alterations","volume":"135","author":"Pangallo","year":"2020","journal-title":"Blood"},{"issue":"34","key":"2024081315054480300_bib42","doi-asserted-by":"crossref","first-page":"E4726","DOI":"10.1073\/pnas.1514105112","article-title":"Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities","volume":"112","author":"Zhang","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2024081315054480300_bib43","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1038\/ncomms7042","article-title":"Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome","volume":"6","author":"Madan","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"2024081315054480300_bib44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1101\/gr.181016.114","article-title":"U2AF1 mutations alter splice site recognition in hematological malignancies","volume":"25","author":"Ilagan","year":"2015","journal-title":"Genome Res"},{"issue":"2","key":"2024081315054480300_bib45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ng.2523","article-title":"Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma","volume":"45","author":"Harbour","year":"2013","journal-title":"Nat Genet"},{"issue":"26","key":"2024081315054480300_bib46","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1182\/blood-2011-08-373159","article-title":"Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness","volume":"118","author":"Rossi","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2024081315054480300_bib47","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1158\/2159-8290.CD-19-1330","article-title":"Mutations in the RNA splicing factor SF3B1 promote tumorigenesis through MYC stabilization","volume":"10","author":"Liu","year":"2020","journal-title":"Cancer Discov"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/15\/3961\/2238072\/blooda_adv-2023-011260-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/15\/3961\/2238072\/blooda_adv-2023-011260-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T11:16:49Z","timestamp":1723547809000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/15\/3961\/516137\/The-E592K-variant-of-SF3B1-creates-unique-RNA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,26]]},"references-count":47,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,8,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023011260","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2802265\/v1","asserted-by":"object"}]},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,26]]}}}